PTSD and Trauma

Recently published articles about PTSD and Trauma

JCP
Predictive Validity of Early Post-Injury CAPS-5 Score for Later PTSD Diagnosis
Original Research

August 5, 2024

A CAPS-5 score of ≥15 provided good predictive accuracy for subsequent PTSD development in the general injured population.
Jae-Min Kim, Ju-Wan Kim, Hee-Ju Kang, et al
Researchers Uncover How Psilocybin Works in the Brain
news

July 18, 2024

Psilocybin disrupts brain networks related to reflective thinking, offering potential therapeutic benefits for mental health issues.
Telehealth Usage Climbs While Payment Changes Threaten Care
news

July 16, 2024

Despite potential cost-sharing challenges, telehealth utilization, especially for mental health services, continues to grow nationally.
JCP
Effects of Low-Dose Ketamine Infusion on Hopelessness and Suicidal Thoughts
Original Research

July 8, 2024

A single infusion of low-dose ketamine resulted in a brief (~4 hour) yet significant reduction in hopelessness.
Wei-Chen Lin, Mu-Hong Chen, Tung-Ping Su, et al
PCC
Prazosin 3 Times Daily for PTSD-Induced Psychological Distress
Case Report

June 25, 2024

This report discusses utilization of a 3-times-daily prazosin dosing scheme during a hospital admission for a patient experiencing severe nightmares and daytime flashbacks associated with PTSD.
Kendall J. Tucker, Trisha T. Villanueva, Miles Fletcher, et al
JCP
Immune Targeted Therapies for Depression: Antidepressant Effects of Monoclonal Antibodies
Narrative Review

June 24, 2024

Immune dysregulation may contribute to treatment resistance in depression. Monoclonal antibodies have shown promise in treating depression when used for inflammatory disorders and may offer new hope for patients...
Mina M. Rizk, Lindsay Bolton, Flurin Cathomas, et al

Recent JCP Articles on PTSD and Trauma

JCP
Psychosis, Inflammatory Biomarkers, and Subtypes of Childhood Trauma
Commentary

May 22, 2024

Dr Nasrallah discusses a recent study by Cuñat et al of the relationship between childhood trauma and inflammation, and why this work is unique and important.
Henry A. Nasrallah
JCP
Barriers to Esketamine Nasal Spray Use in Treatment-Resistant Depression
Original Research

May 6, 2024

Potential barriers to treatment with esketamine nasal spray include travel distance, insurance, low socioeconomic status, and minority communities.
Kruti Joshi, Joshua N. Liberman, Purva Parab, et al
JCP
Systematic Review of the Effects of Cannabis and Cannabinoids in PTSD Symptoms and Symptom Clusters
Systematic Review

February 14, 2024

This review of 14 studies did not find major benefits of cannabinoids in improving overall PTSD symptoms, although some benefits in cluster B and E symptoms were seen. Risks...
Justyne D. Rodas, Tony P. George, Ahmed N. Hassan

Recent PCC Articles on PTSD and Trauma

PCC
Caring for Traumatized Elders
Rounds in the General Hospital

April 23, 2024

Patients with a history of trauma may experience heightened anxiety and fear when faced with medical settings, examinations, or treatments.
Dominique Popescu, Emily Mellen, Ilana Ander, et al
PCC
Transcranial Magnetic Stimulation in Primary Care
Rounds in the General Hospital

March 12, 2024

TMS is a safe, effective, and well-tolerated noninvasive neurotherapeutic procedure that utilizes a strong electromagnetic field to change brain activity in a targeted fashion to treat a variety of...
Mahdi Razafsha, Tracy A. Barbour, Amit Chopra, et al
PCC
Treatment of Trauma-Related Nightmares With Terazosin
Case Report

March 5, 2024

After a failed trial of prazosin, a switch to terazosin was efficacious in reducing the severity and frequency of trauma-related nightmares.
Raechel T. White, Caitlin J. Armijo, Amre A. Elmaoued

The latest news on PTSD and Trauma

Featured PTSD and Trauma Research

PCC
Psilocybin and the Development of Serotonin Toxicity
Case Report

February 29, 2024

This case revealed that unregulated and recreational use of psilocybin in the setting of polypharmacy demonstrates a potential risk for serotonin toxicity that should be diligently monitored.
Avisha D. Amarnani, Melissa F. Free, Ritika Baweja
JCP
What Does a Systematic Review of Cannabis and PTSD Tell Us? That We Need to Learn More
Commentary

February 14, 2024

Dr Ostacher discusses a review by Rodas et al and points to a need for clear answers on how best to advise patients with PTSD and other psychiatric illness...
Michael J. Ostacher
PCC
Intravenous Ketamine vs Intranasal Esketamine for TRD
Letter to the Editor

February 13, 2024

Dr Mansuri and colleagues compare the pros and cons of IV ketamine and intranasal esketamine for treatment-resistant depression.
Zeeshan Mansuri, Bhumika Shah, Garima Yadav, et al
9/11 First Responders Have Ninefold Increased Early Dementia Risk
news

June 13, 2024

WTC first responders who were heavily exposed to toxins have a significantly higher rate of early-onset dementia.
Weekly Mind Reader: Sleep Studies Reveal Suicide Risk Indicators
news

June 7, 2024

In this edition of the Weekly Mind Reader, we share commentary that digs into a bevy of studies that link sleep disorders and suicide.
Why FDA Panel Rejected MDMA for PTSD Treatment
news

June 5, 2024

An FDA advisory panel voted against the use of MDMA – or ecstasy – to treat post-traumatic stress disorder.
JCP
Accounting for Differences in Incident Guideline Discordant Prescribing for PTSD Among Women and Men Veterans
Original Research

June 5, 2024

Women Veterans with PTSD were 67% more likely to initiate a guideline discordant medication. More than half of this effect was explained by bipolar disorder, age, and prior psychiatric...
Kenda R. Stewart Steffensmeier, Katherine Hadlandsmyth, Nancy Bernardy, et al
JCP
The Long Road Toward Equitable MDMA Treatment in the United States
Commentary

May 29, 2024

Kozak and Aaronson discuss challenges in implementation of MDMA-assisted therapy, including insurance and Medicare coverage as well as cultural barriers.
Zofia Kozak, Scott T. Aaronson
JCP
Interpersonal Psychotherapy for PTSD: A Critical Review
Review Article

May 29, 2024

This critical review will give clinicians confidence in considering IPT as an alternative to exposure treatments for posttraumatic stress disorder.
John C. Markowitz

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe